This inventor holds 7 USPTO granted patents. Top assignees: Sandoz Gmbh, Other. Active years: 1984-1994.
Location History:
- Kew, AU (1984)
- Rosanna, 13084 Victoria, AU (1987)
- Rosanna, Victoria, 3084, AU (1990)
- Victoria, AU (1991)
- Rosanna, Victoria, AU (1993)
- Kew, 3101 Victoria, AU (1989 - 1994)
Company Filing History:
1 out of 1,603 
6 out of 834,453 Years Active: 1984-1994
Title: Innovations of William J Louis: Pioneering Cardioselective Agents
Introduction
William J Louis is an accomplished inventor based in Kew, 3101 Victoria, Australia. With a prolific career marked by a total of seven patents, he has made significant contributions to the field of pharmaceuticals, particularly in the development of cardioselective agents. His work continues to influence medical research and therapeutic practices.
Latest Patents
Among his latest innovations are two notable patents involving 3-aminopropoxyphenyl derivatives. These compounds are characterized by various substituents, which enhance their effectiveness as cardioselective beta-adrenoceptor blocking agents. The compounds of formula I, containing a hydroxy group in the 2 position of the 3-aminopropoxy side chain in esterified form, showcase potential therapeutic applications. They are particularly noted for eliciting highly cardioselective beta-1 adrenoceptor blockade and relevant cardiotonic activity. The synthesis of these compounds involves a process of 3-amino-2-oxypropylation of the respective substituted phenol, indicating their innovative chemical preparation.
Career Highlights
William J Louis has had an impressive career in the pharmaceutical industry. He has worked with several reputable companies, including Sandoz GmbH, where he further honed his expertise in drug development and invention. His contributions to pharmaceutical science have been recognized through patents that reflect both his innovative spirit and his dedication to improving medical therapies.
Collaborations
Throughout his career, Louis has collaborated with esteemed professionals, including Andre Stoll and Richard Berthold. These partnerships have likely fostered an environment of creativity and innovation, allowing for the successful development of his patented compounds and aiding in the advancement of their therapeutic applications.
Conclusion
William J Louis stands out as a noteworthy inventor in the realm of pharmaceuticals, particularly through his work on 3-aminopropoxyphenyl derivatives. His contributions illustrate the vital role that innovative thinkers play in enhancing medical therapies and improving patient outcomes. With several patents to his name and a solid track record of professional collaborations, Louis continues to be a significant force in the field of pharmaceutical research and development.